Detection of Carboxyhemefibrinogen and Methemefibrinogen in a Patient with Thrombosis of a HeartMate II Ventricular Assist Device

    loading  Checking for direct PDF access through Ovid

Abstract

Ventricular assist device (VAD) thrombosis is a devastating, potentially fatal complication suffered by patients requiring mechanical circulatory support. We present a patient with thrombosis of a HeartMate II VAD with concurrent hemolysis and increased carbon monoxide formation. Using a specialized thrombelastographic assay, we detected marked plasmatic hypercoagulability mediated in part by the formation of carboxyhemefibrinogen.

Related Topics

    loading  Loading Related Articles